Research Article
Characteristics, Risk Factors, and Outcomes in Acute Kidney Injury Patients: A Retrospective Cross-Sectional Study, Palestine
Table 2
Determinants of mortality in patients with acute kidney injury.
| Characteristic | Categories | Mortality n (%) | value | Adjusted value | Adjusted OR (95% CI) | Yes | No |
| Age OR (95% CI) | 0.93 (0.91–0.96) | <0.001 | <0.001 | 0.943 (0.914–0.973) |
| Comorbidities | Diabetes pt. | 22 (16.4) | 112 (83.6) | 0.225 | Not applied | Not applied | Nondiabetic pt. | 14 (11.2) | 111 (88.8) | CKD | 12 (17.4) | 57 (82.6) | 0.32 | Not applied | Not applied | Non-CKD | 24 (12.6) | 166 (87.4) | Heart disease | 18 (23.4) | 63 (57.6) | 0.014 | 0.003 | 0.305 (0.137–0.677) | No heart disease | 18 (10.1) | 160 (89.9) |
| Complication | Hyperkalemia | 27 (18.1) | 122 (81.9) | 0.02 | 0.123 | 1.962 (0.833–4.621) | No hyperkalemia | 9 (8.2) | 101 (91.8) | Hyperphosphatemia | 14 (19.4) | 58 (80.6) | 0.1 | Not applied | Not applied | No hyperphosphatemia | 22 (11.8) | 165 (88.2) | Hypermagnesemia | 13 (19.4) | 54 (80.6) | 0.13 | Not applied | Not applied | No hypermagnesemia | 23 (12) | 169 (88) | Metabolic acidosis | 6 (33.3) | 12 (66.7) | 0.01 | 0.073 | 2.993 (0.901–9.938) | No metabolic acidosis | 30 (12.4) | 211 (87.6) |
| Stage | Stage 1 | 8 (12.7) | 55 (87.3) | 0.4 | Not applied | Not applied | Stage 2 | 8 (10.5) | 68 (89.5) | Stage 3 | 20 (16.7) | 100 (83.3) |
|
|
The bold values signify values <0.05.
|